Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?

Teladoc Health (NYSE: TDOC) has staged a notable recovery off its lows, but the stock remains under significant pressure from its longer-term trajectory. Shares are up 1.37% over the past week and have gained 3.83% over the past month, yet they remain down 21.21% year-to-date and nearly 36% over the past year. The stock sits well... Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?.